Analyst Ratings for Health Catalyst Inc. (HCAT)
HCAT Rating Summary
HCAT Price Target Summary
- Highest: $4.00 (Evercore ISI)
- Lowest: $1.75 (Wells Fargo)
- Average: $2.81
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$2.81 (+24.7%)
* Over Last 12-Mos
Rating Score: 5.3 / 10
Percentile Rank: 56%
Avg. $ Target:
$2.81 (+24.7%)
* Over Last 12-Mos
Rating Score: 5.3 / 10
Percentile Rank: 56%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/18/2026 | Wells Fargo » Updated 6/26/2026 |
Stan Berenshteyn | Downgrade | Equal Weight (Overweight) |
1.75 (1.00) |
1.22 (2.25) |
84.43% | Details |
| 8/27/2025 | Piper Sandler | Jessica Tassan | Downgrade | Neutral (Overweight) |
4.00 (8.00) |
3.50 (2.25) |
-35.71% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
